Baidu
map
EUR J PHARM SCI 润色咨询

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

出版年份:1993 年文章数:3946 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:7.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2024-05-28 ms5000000002868146 来自北京

    投稿链接是什么,为啥我打不开

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2024-01-08 ms9000001976206462 来自广东省

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2023-12-06 ms2000002084293332 来自甘肃省

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:药理学
    经验分享:10分钟秒拒 哭了

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2018-08-13 Dr. Du

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2023-04-20 12282116m72暂无昵称 来自上海

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:纳米递送系统;动物实验;牙周炎
    经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2016-10-13 yelinghao215

    审稿意见回来了吗?大卫的 2016-09-13 发表::
    研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收

    大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2017-05-17 JYUZ

    投稿命中率:50.0
    经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2018-11-14 rongshi56

    没有版面费173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:
    请问该杂志的版面费贵吗?谢谢

    173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2020-03-17 ms2798897682501839

    从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2207167, encodeId=8650220e1672f, content=投稿链接是什么,为啥我打不开, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28bc9231086, createdName=ms5000000002868146, createdTime=Tue May 28 22:44:38 CST 2024, time=2024-05-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180130, encodeId=bbb8218013085, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:一篇新化合物+药理学研究的稿子,从投稿到接收共三个月,审稿很快。因审稿人问的问题非常专业,回复+补充数据时间花费了一个半月左右。还经历了二修,也修改了整整一个星期,这再次提升了我们稿子的质量,非常感谢这么专业的审稿人。二修返回第二天立马接收,效率杠杠的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb368660953, createdName=ms9000001976206462, createdTime=Mon Jan 08 22:11:23 CST 2024, time=2024-01-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2173349, encodeId=557321e3349b0, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:药理学<br>经验分享:10分钟秒拒 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85938247141, createdName=ms2000002084293332, createdTime=Wed Dec 06 20:00:30 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560071, encodeId=0c8c5600e1c1, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:一篇新化合物+药理的稿子,觉得投欧洲药理,有点亏。就试了EJPS,从投稿到接收4个多月,审稿人很专业,我服气。总体感觉杂志很不错,绝对不是水刊,想灌水的可能到时会浪费时间。编辑友好!值得推荐给真才实学的人投稿!祝福大家,好运!我争取以后每中一篇文章就来medsci写个评论!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=348, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAxm7OEiaSP1WjupgrcWiaiaibFaianxnw9HpHMWSn1Sicd1LA4QLxCMZsMgFianicX32fDCTtJdeyjuWBLg/132, createdBy=b6d02007865, createdName=Dr. Du, createdTime=Mon Aug 13 18:45:00 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2127214, encodeId=2b75212e21430, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:纳米递送系统;动物实验;牙周炎<br>经验分享:开始投的Int J Pharmaceutics,被transfer到EJPS,前期审稿速度有点慢,8周将近2个月才返回一审意见,两个评审人提了很多问题,一一回答,还驳斥了一条建议(现在想想自己胆子真大),好在退修后速度就一路做火箭,从退修给编辑再到录用见刊2周完成。还是很推荐认真做实验的硕博士投稿的,主编很nice,虽然影响因子一般,但医学2区还是很值,祝大家投稿顺利,成果早日发表, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a5102337243, createdName=12282116m72暂无昵称, createdTime=Thu Apr 20 10:13:58 CST 2023, time=2023-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=528171, encodeId=4cfb5281e11b, content=审稿意见回来了吗?<span class="quote">大卫的 2016-09-13 发表::<br>研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收</span>, beContent=大卫的 2016-09-13 发表:: 研究方向:药代动力学;; 刚投了这期刊,withe editor时间为一轴,现在正在审稿,现在很忐忑,希望能被接收, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e91c38967, createdName=yelinghao215, createdTime=Thu Oct 13 08:41:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536798, encodeId=80ac536e983f, content=投稿命中率:50.0<br>经验分享:刚被接受了一篇,就是第一次审稿的时候,耽误了太多时间,中间询问过一次。审稿结束后,几个小时就给了修改的决定。改后再次审稿后,又改了一次,就一个问题。投回去后,几个小时就接受了,这个杂志online速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=444, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2571742971, createdName=JYUZ, createdTime=Wed May 17 10:53:00 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563173, encodeId=3e555631e3ff, content=没有版面费<span class="quote">173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表:<br>请问该杂志的版面费贵吗?谢谢</span>, beContent=173Pwnt1920(暂无昵称) 2017-11-01 09:24:00 发表: 请问该杂志的版面费贵吗?谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=344, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKxWwy2icUqoczXxLdkeib4nXuahtiaLcoExAchnvKtbjD1s7uSvSyFLMSIj0ytEv8uV2FYggCB2Mp7g/132, createdBy=9fbd2074913, createdName=rongshi56, createdTime=Wed Nov 14 00:00:00 CST 2018, time=2018-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858485, encodeId=7fee85848558, content=从刚投稿到一审结束总共花了3个半月,提了不少问题,花了将近一个月修改返回,然后审稿花了一个月接收,从投到在线总共花了差不多半年。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=255, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Tue Mar 17 13:17:00 CST 2020, time=2020-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222775, encodeId=bb4c1222e750c, content=一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3cdf5458328, createdName=金鱼的眼泪, createdTime=Fri May 27 12:12:31 CST 2022, time=2022-05-27, status=1, ipAttribution=)]
    2022-05-27 金鱼的眼泪

    一修的时候更换的共同一作中的一个,直接因更换作者被拒了,还有救吗

    2

    展开2条回复
共33条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map